NCT01390155

Brief Summary

Esophageal electrocardiography (eECG) has important advantages compared to standard ECG recordings. Coronary artery disease leading to myocardial ischemia is very common and has potentially severe consequences for patients. To date, the investigators don't know the influence of ischemia on the eECG. The goal of the present study is to assess ischemic changes of the eECG induced by balloon occlusion of coronary arteries in patients undergoing coronary angiography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2011

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 8, 2011

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

May 24, 2013

Status Verified

May 1, 2013

Enrollment Period

1.8 years

First QC Date

July 1, 2011

Last Update Submit

May 23, 2013

Conditions

Keywords

ElectrocardiographyCoronary Artery DiseaseAtrial FibrillationHeart AtriaCoronary CirculationIschemia

Outcome Measures

Primary Outcomes (1)

  • ST-segment-elevation/depression in the ECG at J-point and 80ms later

    0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 seconds after start of vessel occlusion

Secondary Outcomes (5)

  • Increase/decrease of T-wave amplitude

    0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 seconds after start of vessel occlusion

  • Relative ST-segment-elevation/depression

    0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 seconds after start of vessel occlusion

  • Sensitivity and specificity of the esophageal electrocardiogram detecting ischemic conditions (using the intracoronary ecg as gold standard)

    at the end of occlusion, expected on average to be 60 seconds

  • New U-wave

    during the whole occlusion time, expected on average to be 60 seconds

  • beat-to-beat alternans of the ST-segment

    during the whole occlusion time, expected on average to be 60 seconds

Study Arms (4)

1

Patients undergoing temporary myocardial ischemia produced by a one-minute balloon occlusion of the proximal left anterior descending coronary artery.

Procedure: Measurement of coronary collateral flow index

2

Patients undergoing temporary myocardial ischemia produced by a one-minute balloon occlusion of the proximal left circumflex artery.

Procedure: Measurement of coronary collateral flow index

3

Patients undergoing temporary myocardial ischemia produced by a one-minute occlusion of the proximal right coronary artery.

Procedure: Measurement of coronary collateral flow index

4

Patients undergoing temporary myocardial ischemia produced by a one-minute occlusion of the target vessel.

Procedure: Measurement of coronary collateral flow index

Interventions

One-minute balloon occlusion of the proximal left anterior descending coronary artery inducing a controlled short-time ischemic condition of a part of the myocardium and simultaneous evaluation of collateral flow.

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients referred for elective coronary angiography due to suspected or known coronary artery disease.

You may qualify if:

  • Patients referred for elective coronary angiography
  • Age \>/= 18 years
  • Written informed consent to participate to this study

You may not qualify if:

  • Seve mitral- or aortic valve disease
  • Acute coronary infarction
  • Known bleeding diathesis
  • Systolic blood pressure \>200mmHg
  • History of operations of the esophagus
  • Active disease of the upper respiratory and gastroesophageal tract
  • Radiofrequency ablation of atrial fibrillation, less than six weeks ago
  • Right and left bundle branch block
  • Significant Q-waves in the surface leads as indicators for prior myocardial infarction
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Cardiology, Bern University Hospital

Bern, Canton of Bern, 3010 Bern, Switzerland

Location

MeSH Terms

Conditions

Coronary Artery DiseaseAtrial FibrillationIschemia

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesArrhythmias, CardiacPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Rolf Vogel, MD, MD-PhD

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 1, 2011

First Posted

July 8, 2011

Study Start

July 1, 2011

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

May 24, 2013

Record last verified: 2013-05

Locations